Bristol-Myers bucks trend toward precision medicine

Wall Street Journal

13 March 2016 - Drug company sticks to mass-marketing approach in selling its cancer drug Opdivo.

For more details, go to: http://www.wsj.com/articles/bristol-bucks-trend-toward-precision-medicine-1457912801?mod=asia&mod=djemITPA_t

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine